These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Prolactin enhances CCAAT enhancer-binding protein-beta (C/EBP beta) and peroxisome proliferator-activated receptor gamma (PPAR gamma) messenger RNA expression and stimulates adipogenic conversion of NIH-3T3 cells. Nanbu-Wakao R; Fujitani Y; Masuho Y; Muramatu M; Wakao H Mol Endocrinol; 2000 Feb; 14(2):307-16. PubMed ID: 10674402 [TBL] [Abstract][Full Text] [Related]
7. A novel method for analysis of nuclear receptor function at natural promoters: peroxisome proliferator-activated receptor gamma agonist actions on aP2 gene expression detected using branched DNA messenger RNA quantitation. Burris TP; Pelton PD; Zhou L; Osborne MC; Cryan E; Demarest KT Mol Endocrinol; 1999 Mar; 13(3):410-7. PubMed ID: 10076998 [TBL] [Abstract][Full Text] [Related]
8. Negative regulation of peroxisome proliferator-activated receptor-gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-alpha. Zhang B; Berger J; Hu E; Szalkowski D; White-Carrington S; Spiegelman BM; Moller DE Mol Endocrinol; 1996 Nov; 10(11):1457-66. PubMed ID: 8923470 [TBL] [Abstract][Full Text] [Related]
9. Intimal smooth muscle cells as a target for peroxisome proliferator-activated receptor-gamma ligand therapy. Bishop-Bailey D; Hla T; Warner TD Circ Res; 2002 Aug; 91(3):210-7. PubMed ID: 12169646 [TBL] [Abstract][Full Text] [Related]
10. Inhibitory effect of a proline-to-alanine substitution at codon 12 of peroxisome proliferator-activated receptor-gamma 2 on thiazolidinedione-induced adipogenesis. Masugi J; Tamori Y; Mori H; Koike T; Kasuga M Biochem Biophys Res Commun; 2000 Feb; 268(1):178-82. PubMed ID: 10652233 [TBL] [Abstract][Full Text] [Related]
11. The short- and long-term effects of tumor necrosis factor-alpha and BRL 49653 on peroxisome proliferator-activated receptor (PPAR)gamma2 gene expression and other adipocyte genes. Rosenbaum SE; Greenberg AS Mol Endocrinol; 1998 Aug; 12(8):1150-60. PubMed ID: 9717841 [TBL] [Abstract][Full Text] [Related]
12. Stage-specific effects of a thiazolidinedione on proliferation, differentiation and PPARgamma mRNA expression in 3T3-L1 adipocytes. Takamura T; Nohara E; Nagai Y; Kobayashi K Eur J Pharmacol; 2001 Jun; 422(1-3):23-9. PubMed ID: 11430909 [TBL] [Abstract][Full Text] [Related]
13. PPARgamma activators down-regulate the expression of PPARgamma in 3T3-L1 adipocytes. Camp HS; Whitton AL; Tafuri SR FEBS Lett; 1999 Mar; 447(2-3):186-90. PubMed ID: 10214942 [TBL] [Abstract][Full Text] [Related]
14. A synthetic triterpenoid, 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO), is a ligand for the peroxisome proliferator-activated receptor gamma. Wang Y; Porter WW; Suh N; Honda T; Gribble GW; Leesnitzer LM; Plunket KD; Mangelsdorf DJ; Blanchard SG; Willson TM; Sporn MB Mol Endocrinol; 2000 Oct; 14(10):1550-6. PubMed ID: 11043571 [TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptor-gamma represses GLUT4 promoter activity in primary adipocytes, and rosiglitazone alleviates this effect. Armoni M; Kritz N; Harel C; Bar-Yoseph F; Chen H; Quon MJ; Karnieli E J Biol Chem; 2003 Aug; 278(33):30614-23. PubMed ID: 12777391 [TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptor gamma-dependent repression of the inducible nitric oxide synthase gene. Li M; Pascual G; Glass CK Mol Cell Biol; 2000 Jul; 20(13):4699-707. PubMed ID: 10848596 [TBL] [Abstract][Full Text] [Related]
17. Inflammatory mechanisms in Alzheimer's disease: inhibition of beta-amyloid-stimulated proinflammatory responses and neurotoxicity by PPARgamma agonists. Combs CK; Johnson DE; Karlo JC; Cannady SB; Landreth GE J Neurosci; 2000 Jan; 20(2):558-67. PubMed ID: 10632585 [TBL] [Abstract][Full Text] [Related]
18. Control of COX-2 gene expression through peroxisome proliferator-activated receptor gamma in human cervical cancer cells. Han S; Inoue H; Flowers LC; Sidell N Clin Cancer Res; 2003 Oct; 9(12):4627-35. PubMed ID: 14555539 [TBL] [Abstract][Full Text] [Related]
19. YM268 increases the glucose uptake, cell differentiation, and mRNA expression of glucose transporter in 3T3-L1 adipocytes. Shimaya A; Kurosaki E; Shioduka K; Nakano R; Shibasaki M; Shikama H Horm Metab Res; 1998 Sep; 30(9):543-8. PubMed ID: 9808320 [TBL] [Abstract][Full Text] [Related]
20. Cyclooxygenase-2 expression by nonsteroidal anti-inflammatory drugs in human airway smooth muscle cells: role of peroxisome proliferator-activated receptors. Pang L; Nie M; Corbett L; Knox AJ J Immunol; 2003 Jan; 170(2):1043-51. PubMed ID: 12517972 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]